Disclosure Of Fair Value Measurement [Text Block]

Xspray Pharma - Filing #679276

Concept As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
Disclosure of fair value measurement [text block]
Disclosure of fair value measurement of assets [text block]
Disclosure of fair value measurement of assets [abstract]
Disclosure of fair value measurement of assets [line items]
Assets
765 263 SEK
585 430 SEK
Reconciliation of changes in fair value measurement, assets [abstract]
Disclosure of fair value measurement of equity [text block]
Disclosure of fair value measurement of equity [abstract]
Disclosure of fair value measurement of equity [line items]
Equity
31 253 SEK
184,000 SEK
1 216 093 SEK
554 724 SEK
693 413 SEK
976,000 SEK
556 019 SEK
375 057 SEK
22 680 SEK
- SEK
976,000 SEK
907 420 SEK
243 387 SEK
591 752 SEK
976,000 SEK
813 483 SEK
- SEK
20 680 SEK
Reconciliation of changes in fair value measurement, entity's own equity instruments [abstract]

Talk to a Data Expert

Have a question? We'll get back to you promptly.